↓ Skip to main content

Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine

Overview of attention for article published in Journal of Molecular Medicine, April 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
93 Mendeley
Title
Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine
Published in
Journal of Molecular Medicine, April 2018
DOI 10.1007/s00109-018-1638-5
Pubmed ID
Authors

Charlotte A Lee, Siddharth Sinha, Emer Fitzpatrick, Anil Dhawan

Abstract

Human hepatocyte transplantation has been actively perused as an alternative to liver replacement for acute liver failure and liver-based metabolic defects. Current challenges in this field include a limited cell source, reduced cell viability following cryopreservation and poor engraftment of cells into the recipient liver with consequent limited life span. As a result, alternative stem cell sources such as pluripotent stem cells, fibroblasts, hepatic progenitor cells, amniotic epithelial cells and mesenchymal stem/stromal cells (MSCs) can be used to generate induced hepatocyte like cells (HLC) with each technique exhibiting advantages and disadvantages. HLCs may have comparable function to primary human hepatocytes and could offer patient-specific treatment. However, long-term functionality of transplanted HLCs and the potential oncogenic risks of using stem cells have yet to be established. The immunomodulatory effects of MSCs are promising, and multiple clinical trials are investigating their effect in cirrhosis and acute liver failure. Here, we review the current status of hepatocyte transplantation, alternative cell sources to primary human hepatocytes and their potential in liver regeneration. We also describe recent clinical trials using hepatocytes derived from stem cells and their role in improving the phenotype of several liver diseases.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 93 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 20%
Researcher 16 17%
Student > Bachelor 11 12%
Student > Master 8 9%
Student > Doctoral Student 5 5%
Other 8 9%
Unknown 26 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 25 27%
Medicine and Dentistry 16 17%
Agricultural and Biological Sciences 10 11%
Nursing and Health Professions 4 4%
Engineering 2 2%
Other 4 4%
Unknown 32 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 May 2018.
All research outputs
#13,077,497
of 23,045,021 outputs
Outputs from Journal of Molecular Medicine
#1,025
of 1,554 outputs
Outputs of similar age
#158,373
of 326,487 outputs
Outputs of similar age from Journal of Molecular Medicine
#4
of 15 outputs
Altmetric has tracked 23,045,021 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,554 research outputs from this source. They receive a mean Attention Score of 5.0. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,487 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.